Filter
119
Filtered Results: 119
Text search:
Barnes,
H.
Featured
Recommendations
7
New Publications
7
Language
Document type
No document type
56
Studies & Reports
38
Guidelines
13
Manuals
5
Strategic & Response Plan
3
Training Material
2
Fact sheets
2
Countries / Regions
Global
7
Western and Central Europe
4
Russia
4
India
3
Brazil
3
Latin America and the Carribbean
3
Africa
3
Mali
2
Uganda
2
Niger
2
Egypt
2
Syria
2
Kenya
2
Peru
2
Ukraine
2
Middle East and North Africa
2
South–East Asia Region
2
Eastern Europe
2
Guinea
1
Burkina Faso
1
Sierra Leone
1
Liberia
1
Nigeria
1
Senegal
1
Congo, Democratic Republic of
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Cameroon
1
Ghana
1
Haiti
1
Somalia
1
Nepal
1
Pakistan
1
Iraq
1
Jordan
1
Afghanistan
1
Germany
1
Lebanon
1
Chad
1
China
1
Indonesia
1
Mauritania
1
South Africa
1
Bangladesh
1
Sudan
1
Benin
1
Argentina
1
Dominican Republic
1
Cuba
1
Colombia
1
Honduras
1
Ecuador
1
El Salvador
1
Bolivia
1
Libya
1
Guatemala
1
Madagascar
1
Mexico
1
Nicaragua
1
Sri Lanka
1
Chile
1
Yemen
1
Asia
1
Venezuela
1
Congo-Brazzaville
1
Qatar
1
Kazakhstan
1
France
1
Tunisia
1
Spain
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Public Health
21
Countries
17
Clinical Guidelines
11
Women & Child Health
3
Key Resources
1
Toolboxes
Mental Health
18
NCDs
16
Disability
13
COVID-19
11
Planetary Health
10
NTDs
9
Rapid Response
7
HIV
6
TB
6
AMR
3
Pharmacy
3
Ebola
2
Cholera
2
Social Ethics
2
Caregiver
2
Polio
1
Conflict
1
Natural Hazards
1
Refugee
1
Global Health Education
1
Health Financing Toolbox
1
PNAS 119 (8) e2113947119 | https://doi.org/10.1073/pnas.2113947119
Environmental exposure to active pharmaceutical ingredients (APIs) can have negative effects on the health of ecosystems and humans. While numerous studies have monitored APIs in rivers, these employ different analytical methods, m...
February 2020Earth's Future 8(2):e2019EF001377.The water planetary boundary attempts to provide a global limit to anthropogenic water cycle modifications, but it has been challenging to translate and apply it to the regional and local scales at which water problems and management typically occur. We...
Tools and practical guidance for achieving high uptake
PLoS Neglected Tropical diseases August 16, 2021 https://doi.org/10.1371/journal.pntd.0009697
Chagas disease, also known as American trypanosomiasis, is a neglected tropical disease transmitted by triatomine insects, first identified in 1909. Chagas disease affects approximately 6–7 million peop...
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio...
PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t...
The chapter Dementia in Latin America and the Caribbean: Prevalence, Incidence, Impact, and Trends over Time, is part of the publication series titled “Decade of Healthy Aging: situation and challenges”. This document aims to provide an outline of the current situation in Latin America and the C...
This paper introduces a new dataset of official financing—including foreign aid and other forms of concessional and non-concessional state financing—from China to 138 countries between 2000 and 2014. We use these data to investigate whether and to what extent Chinese aid affects economic growth ...
The environment in which young people live, learn and play significantly affects their decisions about whether to consume alcohol. Environmental factors are the main risk factors driving alcohol consumption and related harm among young people. Environments that normalize alcohol consumption – term...
Many features of the environment have been found to exert an important influence on cardiovascular disease (CVD) risk, progression, and severity. Changes in the environment due to migration to different geographic locations, modifications in lifestyle choices, and shifts in social policies and cultu...
There is increasing interest in understanding the role of air pollution as one of the greatest threats to human health worldwide. Nine of 10 individuals breathe air with polluted compounds that have a great impact on lung tissue. The nature of the relationship is complex, and new or updated data are...
The article "Under- and over-diagnosis of COPD: a global perspective" reviews the worldwide variation in the prevalence of chronic obstructive pulmonary disease (COPD) and issues related to its misdiagnosis. It highlights that COPD is under-diagnosed due to factors such as limited access to spiromet...
The article discusses the significant impact of chronic obstructive pulmonary disease (COPD) as a global health issue, with cigarette smoking as the main risk factor. However, in developing countries, the causes of COPD are often multifactorial, involving environmental tobacco smoke, biomass fuel sm...
The goal of asthma treatment is to obtain clinical control and reduce future risks to the patient. To reach this goal in children with asthma, ongoing monitoring is essential. While all components of asthma, such as symptoms, lung function, bronchial hyperresponsiveness and inflammation, may exist i...
Asthma is the most common chronic respiratory disease (CRD) worldwide and is estimated to affect 262 million causing significant mortality and morbidity, and has emerged as an important public health problem in many Latin American (LA) countries over the last 30 or so years. LA is a highly diverse r...
Asthma is the most common non-communicable disease in children and remains one of the most common throughout the life course. The great majority of the burden of this disease is seen in low-income and middle-income countries (LMICs), which have disproportionately high asthma-related mortality relati...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the...
